Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome-Reference-Cited by-同舟云学术

Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome

Published:2015-04-10 Issue:1 Volume:10 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Pal Abhijit Ricky,Langereis Eveline J,Saif Muhammad A,Mercer Jean,Church Heather J,Tylee Karen L,Wynn Robert F,Wijburg Frits A,Jones Simon A,Bruce Iain A,Bigger Brian W

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics(clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-015-0255-4.pdf

Reference34 articles.

1. Moore D, Connock MJ, Wraith E, Lavery C. The prevalence of and survival in Mucopolysaccharidosis I: Hurler: Hurler-Scheie and Scheie syndromes in the UK. Orphanet J Rare Dis. 2008;3:24.

2. Murphy AM, Lambert D, Treacy EP, O’Meara A, Lynch SA. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic. Arch Dis Child. 2009;94(1):52–4.

3. Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology (Oxford). 2011;50 Suppl 5:v4–12.

4. Muenzer J, Wraith JE, Clarke LA. Mucopolysaccharidosis I: Management and Treatment Guidelines. Pediatrics. 2009;123(1):19–29.

5. de Ru MH, Boelens JJ, Das AM, Jones SA, van der Lee JH, Mahlaoui N, et al. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis. 2011;6:55.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sleep disorders in neurological disorders and sleep-related movement disorders in children less than 2 years of age;Assessment and Treatment of Infant Sleep;2025

2. Glycosaminoglycans in mucopolysaccharidoses and other disorders;Advances in Clinical Chemistry;2024

3. Pediatric Sleep Respiratory Disorders: A Narrative Review of Epidemiology and Risk Factors;Children;2023-05-27

4. Modifying enzyme replacement therapy – A perspective;Journal of Cellular and Molecular Medicine;2022-12-25

5. MPSI Manifestations and Treatment Outcome: Skeletal Focus;International Journal of Molecular Sciences;2022-09-22